Latest Articlesddd
Sequenom (SQNM) is no more there as a separate biotech company, as it is on its …
Immunotherapy Engineered T-Cell Therapy Is Here to Stay Articles aimed at undermining the value of the …
We do expect some selling of Array today after AstraZeneca’s announced negative results from Phase 3 …
ANOTHER MISLEADING STORY This article was corrected after being posted. Read our apology at the end …
Investors in the stock market know that stocks yo-yo all the time. Sometimes, the yo-yoing becomes …
EMA’s created Priority Medicines (PRIME) regulatory initiative for products which the European agency rules they are …
The FDA advisory committee members’ inability to rule for or against the approval of Valeant (VRX) …
Important news is the news that informs about successful achievements that make a difference in treating …
News about approvals or insinuations about almost guaranteed future approvals of products that promise improving the …
The FDA approved INSIGHTEC firm’s Exablate Neuro system for the non-invasive treatment of essential tremor (ET) …
JUNO Juno Therapeutics (JUNO), the CAR T developing firm that aims at revolutionizing cancer treatment …
AMGEN Repatha is the human monoclonal antibody that blocks a protein called proprotein convertase subtilisin/kexin type …
Juno Therapeutics (JUNO) announced that the U.S. Food and Drug Administration (FDA) has placed a clinical …
Good news is not always great news that makes a difference. In the drug industry, clinical …
PsiOxus Therapeutics’ adenovirus product in combination with Opdivo (nivo-lumab) for late-stage cancers. Bristol-Myers Squibb (BMY) …
- Tesaro's (TSRO) drug niraparib significantly improved progression-free survival for patients with ovarian cancer in both …
The Royal Divorce On Sunday, the next day after the announcement of the British referendum’s results, …
GRAFT VERSUS HOST DISEASE (GVHD) INCYTE (INCY) HAS SEVERAL GOOD NEWS. As a matter of fact, …
Le CompaGnon Part 2 Wednesday June 22, 2016 From the American Society of Clinical Oncology (ASCO) …
Innoviva (INVA) and GlaxoSmithKline plc (GSK) announced positive results from the pivotal Phase 3 FULFIL study …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
